TRA2B p.Ala17Pro
c.49G>C · VCV3460644
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1008 | likely benign |
|---|---|---|
| REVEL | 0.208 | benign-leaning |
| SaProt | LLR -5.18 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | Δ0.42 | acceptor gain · deltas |
| Pangolin | Δ0.28 | gain · loss 0.12 · agrees with SpliceAI · independent |
| Constraint at this position | ||
| Conservation | phyloP 6 | GERP 2.3, phastCons 1 |
| Regional constraint | o/e 0.70 | unconstrained · MANE · 12 kb · p 0.00064 · regional, not allelic |
| Overall | ||
| CADD | 29.4 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- TRA2B
- Protein
- p.Ala17Pro
- Coding
- c.49G>C
- MANE Select
- NM_004593
- Type
- single nucleotide variant
- Location
- chr3:185926722 (GRCh38)
- Gene constraint
- LOEUF 0.528 · pLI 0.96 (gnomAD)
- Structure
- AlphaFold pLDDT 57.18 · 4 PDB
- Residue 17
- the 'disordered' region
Similar variants
- TRA2B p.Arg74His Uncertain significance ★ ⚠ same condition
- TRA2B p.Arg82His Uncertain significance ★ ⚠ same condition
- TRA2B p.Arg91Cys Uncertain significance ★ ⚠ same condition
- TRA2B p.Asn8Thr Uncertain significance ★ ⚠ same condition
- TRA2B p.Asp146Asn Uncertain significance ★ same condition
- TRA2B p.Asp257Glu Uncertain significance ★ ⚠ same condition
- TRA2B p.His98Arg Uncertain significance ★ ⚠ same condition
- TRA2B p.Ser270Thr Uncertain significance ★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tra2b-p-ala17pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown